Patent · US Active

Crystal forms of astaxanthin

US7563935B2 · kind B2 · utility

1Cited by

8References

42Claims

0Family size

Assignee

Phares Pharmaceutical Research, N.V. · NL

Inventors

Steve Leigh · Muttenz, CH
Mathew Louis Steven Leigh · London, GB
Peter Van Hoogevest · Riehen, CH

Key dates

Filing date	Feb 15, 2008
Grant date	Jul 21, 2009
Priority date	—
Expiry date	Feb 15, 2028

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07C403/24
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

Mixtures of specific crystal forms of astaxanthin and the individual crystal forms designated crystal Form I and II and disclosed together with methods for preparing said crystal Forms. Methods for preparing nutritional dosage forms including the disclosed astaxanthin crystal forms for the life science industry are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.